News of the WeekNewsmaker Interview

Corey Goodman, Post-Pfizer, On the Allure of Enterprise

See allHide authors and affiliations

Science  08 May 2009:
Vol. 324, Issue 5928, pp. 706
DOI: 10.1126/science.324_706

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


In 2001, neuroscientist Corey Goodman took leave from a tenured professorship at the University of California, Berkeley, and gave up his post as a Howard Hughes Medical Institute investigator to dive into the world of small biotechnology companies. Then in 2007, he joined pharmaceutical behemoth Pfizer, heading up its new Biotherapeutics and Bioinnovation Center. Its goal was to put Pfizer, which like all of big pharma is struggling to keep its pipeline filled with ideas, on a path to developing new, more innovative therapeutics. Goodman left that post in April, saying he'd accomplished what he set out to do. He spoke with Science last week; the interview has been edited for brevity.